IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Medicxi Ventures Management (Jersey) Ltd

Q3 2023 Holdings

Filed 2023-10-18 | 6 holdings | $313.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$129.2M19,963,15741.2%
Vaxcyte Inc(PCVX)COM92243G108$53.5M1,049,89317.1%
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$39.0M3,760,86912.5%
Merus N VCOMN5749R100$37.7M1,600,00012.0%
Aura Biosciences Inc(AURA)COM05153U107$27.3M3,039,8928.7%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$26.5M2,869,5658.5%